A Patient With Novel PPP1CB -ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report.

Jin C, Li C, Zhang T, Qiu J, Guo M, He Z, Wu D

Open source

DOI
10.1016/j.jtocrr.2026.100993
Published
2026 Jun
Container
JTO clinical and research reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2026.100993,
  title = {A Patient With Novel PPP1CB -ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report.},
  author = {Jin C and Li C and Zhang T and Qiu J and Guo M and He Z and Wu D},
  year = {2026},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2026.100993},
  url = {https://doi.org/10.1016/j.jtocrr.2026.100993}
}

RIS

TY  - JOUR
TI  - A Patient With Novel PPP1CB -ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report.
AU  - Jin C
AU  - Li C
AU  - Zhang T
AU  - Qiu J
AU  - Guo M
AU  - He Z
AU  - Wu D
PY  - 2026
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2026.100993
UR  - https://doi.org/10.1016/j.jtocrr.2026.100993
ER  - 

APA

C, J., C, L., T, Z., J, Q., M, G., Z, H., & D, W. (2026). A Patient With Novel PPP1CB -ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2026.100993

Source records